Search Results - "Drug side effects"

Beyond lab animals.

Authors: Reardon, Sara¹

Source: Science. 8/14/2025, Vol. 389 Issue 6761, p676-679. 4p.

Prevalence and Characteristics of Deoxycholate and Liposomal Amphotericin B Adverse Reactions in a Third‐Level Care Hospital: A Retrospective Observational Study.

Authors: Vargas, Thalia Berenice Jacobo Portugal, Miriam del Carmen Carrasco Saldaña, Renata Báez et al.

Source: Journal of Clinical Pharmacy & Therapeutics. 6/21/2026, Vol. 2026, p1-7. 7p.

Systemic Cancer Therapy‐Related Adverse Drug Reactions and Associated Clinical Outcomes Among Lymphoma Patients at Kenyatta National Hospital.

Authors: Mochere, Ivy Kerubo Degu, Amsalu Xu, Yue

Source: Journal of Clinical Pharmacy & Therapeutics. 6/18/2026, Vol. 2026, p1-9. 9p.

Causality assessment of adverse events by healthcare professionals in an academic hospital setting: a descriptive retrospective study.

Authors: Corbin, Sonia Lavallée, Maude Pradhan, Pallavi et al.

Source: Canadian Journal of Physiology & Pharmacology. 2025, Vol. 103 Issue 5, p172-181. 10p.

The Latest Ozempic Side Effect? It May Make You Less Violent.

Authors: Murray, Conor (AUTHOR)

Source: Forbes.com. 6/17/2026, pN.PAG-N.PAG. 1p.

De novo clinical endocrine immune-related adverse events during immune checkpoint inhibitor therapy in adults with cancer (2000–2025) – a scoping review.

Authors: Pillay, S¹ (AUTHOR) drspillay@iafrica.com

Source: Journal of Endocrinology, Metabolism & Diabetes of South Africa. Jun2026, p1-6. 6p. 1 Illustration.

抗体药物偶联物治疗肺癌不良反应多学科 管理专家共识 (2025 版).

Alternate Title: Consensus of Chinese experts on the multidisciplinary management of adverse reactions to antibody-drug conjugates in the treatment of lung cancer (2025 edition).

Source: Chinese Journal of Oncology. Jun2026, Vol. 48 Issue 6, p703-723. 21p.

Patterns of Spontaneous Adverse Drug Reaction Reporting in Germany From 2012 to 2021.

Authors: Dubrall, Diana Domgörgen, Severin Christ, Patrick et al.

Source: Pharmacology Research & Perspectives. Jun2026, Vol. 14 Issue 3, p1-10. 10p.

Magnitude, Preventability, and Determinants of Adverse Drug Reactions Among Hospitalized Obstetric Patients in Ethiopia: A Prospective Observational Study.

Authors: Tarekegn, Getachew Yitayew Tsegaw, Endalemaw Dagnew, Fisseha Nigussie et al.

Source: Pharmacology Research & Perspectives. Jun2026, Vol. 14 Issue 3, p1-11. 11p.

Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China.

Authors: Wang, Jinlin Dong, Youhong Cao, Fengjun et al.

Source: Thoracic Cancer. Jun2026, Vol. 17 Issue 11, p1-12. 12p.

An Account of Acute Adverse Drug Reactions Occurring in a Day-Care Chemotherapy Unit of a Tertiary Care Cancer Hospital—A Prospective Observational Study.

Authors: Sekhar, Gonepalli Pravanika Mallavarapu, Krishna Mohan Rajappa, Senthil et al.

Source: Indian Journal of Medical & Paediatric Oncology. Jun2026, Vol. 47 Issue 3, p197-202. 6p.

Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study.

Authors: Gossec, Laure Bouguen, Guillaume Dellal, Azeddine et al.

Source: Rheumatology & Therapy. Jun2026, Vol. 13 Issue 3, p645-658. 14p.

No Identifiable Primary, Only Metastases: Case Report of a Small Round Blue Cell Tumor Consistent With Ewing Sarcoma Presenting With Multisystem Spread in a Young Woman.

Authors: Irfan, Simra Muneeb, Ahmed Muhammad Zohaib Uddin, Mallick et al.

Source: Clinical Medicine Insights: Case Reports. 6/1/2026, Vol. 19, p1-7. 7p.

Can Belantamab mafodotin cause macro LDH?

Authors: Hakakian, Leehe Shragai, Tamir Trestman, Svetlana et al.

Source: Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1561-1566. 6p.

Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study.

Authors: Michaels-Igbokwe, Christine Lu, Hui Winfree, Katherine B. et al.

Source: Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1548-1560. 13p.

Drug-induced Acneiform Breakout in a Postpartum Psychosis Patient: A Case Report with Literature Review.

Authors: M, Deepalakshmi M, Sudharsan S, Rajalakshmi et al.

Source: Journal of Pharmacology & Pharmacotherapeutics. Jun2026, Vol. 17 Issue 2, p308-314. 7p.

Identification of drug-related cardiovascular risks: A comprehensive analysis using the FAERS database (2004–2024).

Authors: Qin, Naishen Gan, Yumei Ouyang, Jun et al.

Source: PLoS ONE. 6/1/2026, Vol. 21 Issue 6, p1-14. 14p.

Association of Guillain–Barré Syndrome With Nonavalent Human Papillomavirus Vaccine: A Postmarketing Drug Safety Study.

Authors: González Mariño, Mario Arturo Sharma, Karuna

Source: Obstetrics & Gynecology International. 5/31/2026, Vol. 2026, p1-5. 5p.

Early treatment interruption and nutritional status as predictors of mortality in Mycobacterium avium complex pulmonary disease.

Authors: Hong, Hye Young Park, Youngmok Kim, Song Yee et al.

Source: PLoS ONE. 5/27/2026, Vol. 21 Issue 5, p1-13. 13p.

Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.

Authors: Pan, Qiaoling Chen, Hang Pan, Hanbo et al.

Source: PLoS ONE. 5/22/2026, Vol. 21 Issue 5, p1-14. 14p.